Free. Unsubscribe any time.
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. filed 34 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 140 transactions and 842,050 shares. None carries the SEC's AFF10B5ONE flag; all 34 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-11, came 23 days after the one before it (2026-08-19) and reports 13 transactions against 17 in the filing before it.
- The sales it reports total 60,000 shares, the same as the 60,000 in the filing before it.
- Its 34 plan statements rank 175th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 34 filings on file run from 2025-01-07 to 2026-09-11, and state 2 plan adoption dates, from 2024-09-18 to 2025-06-11.
Trades in HALOZYME THERAPEUTICS, INC. 140
- Henderson Jeffrey William — 2025-01-06 · S · 10,000 shares
- Henderson Jeffrey William — 2025-02-03 · S · 1,100 shares
- Henderson Jeffrey William — 2025-02-03 · S · 3,900 shares
- LaBarre Michael J. — 2025-02-25 · S · 9,300 shares
- LaBarre Michael J. — 2025-02-25 · S · 700 shares
- LaBarre Michael J. — 2025-02-26 · S · 9,400 shares
- LaBarre Michael J. — 2025-02-26 · S · 600 shares
- LaBarre Michael J. — 2025-02-27 · S · 1,597 shares
- LaBarre Michael J. — 2025-02-27 · S · 100 shares
- Henderson Jeffrey William — 2025-03-03 · S · 1,795 shares
- Henderson Jeffrey William — 2025-03-03 · S · 3,205 shares
- Henderson Jeffrey William — 2025-04-01 · S · 503 shares
Adoption dates in HALOZYME THERAPEUTICS, INC. 2
- 2024-09-18 — stated in 1 filing
- 2025-06-11 — stated in 2 filings
Results prints in HALOZYME THERAPEUTICS, INC. 9
- 2025-01-08
- 2025-02-18
- 2025-05-06
- 2025-08-05
- 2025-11-03
- 2026-01-28
- 2026-02-17
- 2026-05-11
- 2026-08-06
Trades before a print in HALOZYME THERAPEUTICS, INC. 4
- 0 days before the 2026-05-11 print — 2026-05-11 · S · Torley Helen · 9,725 shares
- 0 days before the 2026-05-11 print — 2026-05-11 · S · Torley Helen · 3,575 shares
- 0 days before the 2026-05-11 print — 2026-05-11 · S · Torley Helen · 6,700 shares
- 2 days before the 2025-01-08 print — 2025-01-06 · S · Henderson Jeffrey William · 10,000 shares
- 8 days before the 2025-05-06 print — 2025-04-28 · S · Henderson Jeffrey William · 4,297 shares
- 8 days before the 2025-05-06 print — 2025-04-28 · S · Henderson Jeffrey William · 200 shares
- 10 days before the 2026-05-11 print — 2026-05-01 · S · Connaughton Bernadette · 1,625 shares
- 12 days before the 2026-02-17 print — 2026-02-05 · S · Torley Helen · 5,376 shares
- 12 days before the 2026-02-17 print — 2026-02-05 · S · Torley Helen · 4,624 shares
- 13 days before the 2026-02-17 print — 2026-02-04 · S · Torley Helen · 9,900 shares
- 13 days before the 2026-02-17 print — 2026-02-04 · S · Torley Helen · 10,100 shares
- 14 days before the 2026-02-17 print — 2026-02-03 · S · Torley Helen · 2,551 shares
Interval to HALOZYME THERAPEUTICS, INC.’s next reported results date
How the interval and sources are counted →
- 4within 5 days
- 7within 10 days
- 0shortest, days
- 19no later print
- Henderson Jeffrey William 2025-01-06 · S · 2 days before the 2025-01-08 print
- Henderson Jeffrey William 2025-04-28 · S · 8 days before the 2025-05-06 print
- Henderson Jeffrey William 2025-04-28 · S · 8 days before the 2025-05-06 print
- Connaughton Bernadette 2026-05-01 · S · 10 days before the 2026-05-11 print
- Torley Helen 2026-05-11 · S · 0 days before the 2026-05-11 print · PRESIDENT AND CEO
- Torley Helen 2026-05-11 · S · 0 days before the 2026-05-11 print · PRESIDENT AND CEO
- Torley Helen 2026-05-11 · S · 0 days before the 2026-05-11 print · PRESIDENT AND CEO
Adoption dates HALOZYME THERAPEUTICS, INC. states
- 2024-09-18 in 1 filing
- 2025-06-11 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 18, 2024”
Reported results dates on file
- 2025-01-08
- 2025-02-18
- 2025-05-06
- 2025-08-05
- 2025-11-03
- 2026-01-28
- 2026-02-17
- 2026-05-11
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.